Close Menu

NEW YORK – Electronic genome mapping company Nabsys said today that it has raised $21 million in an equity financing round that was led by Hitachi High-Technologies.

Other investors in the round were not disclosed.

The Providence, Rhode Island-based company plans to use the funding to finish developing and commercially launch its HD-Mapping whole-genome electronic mapping platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.